Parenteral Drug Delivery

Conventional and novel parenteral drug delivery systems play a pivotal role in enhancing the efficacy and bioavailability of pharmaceutical compounds. Conventional formulations like solutions, parenteral suspensions, emulsions, and microemulsions have been integral to delivering a wide range of therapeutics. However, the limitations of these systems, such as poor stability and solubility, have driven innovation towards novel alternatives. Novel parenteral drug delivery systems, including nanosuspensions, lipid-based carriers like nanostructured lipid carriers and solid lipid nanoparticles, liposomes, and micelles, have emerged as promising solutions. These systems offer benefits such as enhanced drug solubility, controlled release, and targeted drug delivery, overcoming challenges posed by conventional counterparts. By harnessing nanotechnology and lipid-based carriers, these novel approaches offer superior drug delivery options, ensuring better patient compliance and therapeutic outcomes. The continuous evolution of drug delivery techniques holds great promise for the pharmaceutical industry, with these innovations addressing the need for improved drug delivery efficiency and safety.